Close Menu

siRNA

In doing so, SIROCCO is meeting its goal of making its discoveries and technologies freely accessible to the research community.

IP Update: Feb 26, 2009

Premium

USPTO Publishes Six RNAi-Related Patent Applications

Thomas Cech, Jeffery Vick

Strands: Feb 26, 2009

Premium

Tekmira Pharmaceuticals, MDRNA

Sylentis will perform the initial clinical trial on its own in Spain for logistical reasons, but expects to later test the topically administered drug in other countries, including the US, according to a company official.

IP Update: Feb 19, 2009

Premium

USPTO Publishes Six RNAi-Related Patent Applications

Strands: Feb 19, 2009

Premium

MDRNA, Roche, Arrowhead Research, Rosetta Genomics, Alnylam Pharmaceuticals, Genesis Research and Development

During a conference call held this week to discuss Arrowhead Research's fiscal first-quarter financial results, President and CEO Christopher Anzalone said that the company was in a position to stay afloat for at least the next nine months.

The researchers evaluated the effects of small molecules in both in vitro enzymatic assays and cell-based assays to develop what they said are the first isoform-selective phospholipase D inhibitors, which are potential antimetastatic agents.

Pages

The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.